0001188112-11-001558.txt : 20110524 0001188112-11-001558.hdr.sgml : 20110524 20110524164008 ACCESSION NUMBER: 0001188112-11-001558 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110520 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20110524 DATE AS OF CHANGE: 20110524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THERAGENICS CORP CENTRAL INDEX KEY: 0000795551 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 581528626 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14339 FILM NUMBER: 11868431 BUSINESS ADDRESS: STREET 1: 5203 BRISTOL INDUSTRIAL WAY CITY: BUFORD STATE: GA ZIP: 30518 BUSINESS PHONE: 7702710233 MAIL ADDRESS: STREET 1: 5203 BRISTOL INDUSTRIAL WAY CITY: BUFORD STATE: GA ZIP: 30518 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR MEDICINE INC DATE OF NAME CHANGE: 19860902 8-K 1 t70782_8k.htm FORM 8-K t70782_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 20, 2011

THERAGENICS CORPORATION®
(Exact name of registrant as specified in charter)


Delaware
001-14339
58-1528626
(State of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)


5203 Bristol Industrial Way
Buford, Georgia 30518
(Address of principal executive offices / Zip Code)


(770) 271-0233
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 o Written communications pursuant to Rule 425 under the Securities Act. 
   
 o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
   
 o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. 
   
 o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. 
   
      
 
 
 
 
Item 5.07
Submission of Matters to a Vote of Security Holders.
 
Set forth below is a brief description of each matter voted upon at Theragenics Corporation’s 2011 annual meeting of stockholders held on May 20, 2011, and the voting results with respect to each matter.
 
1.
A proposal to elect two Class I directors to serve for a term expiring in 2014:
 
 
Class I Director
  
Votes For
    
Votes
Withheld
    
Broker
Non-votes
  
                     
John V. Herndon
   18,058,180     564,397       8,044,967  
                     
Peter A. A. Saunders
   17,599,315     1,023,262       8,044,967  
 
 
2.
A proposal to ratify the appointment of Dixon Hughes PLLC as the Company’s independent auditor for the year ending December 31, 2011:
 
 
 
For
    
Against
    
Abstentions
    
Broker
Non-votes
  
                       
  26,405,461     135,478     127,205     0  
 
 
Pursuant to the foregoing votes, Mr. Herndon and Mr. Saunders were elected to serve as Class I directors and Dixon Hughes PLLC was ratified as the Company’s independent auditors for the Company’s fiscal year ending December 31, 2011.
 
 
2
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
    THERAGENICS CORPORATION  
    (Registrant)  
       
Dated: May 24, 2011
 
By:
/s/ M. Christine Jacobs                                                   
      M. Christine Jacobs  
      Chief Executive Officer  
         
 
3